目的建立固相萃取反相高效液相色谱法测定人血浆麦考酚酸(MPA)浓度,探讨MPA与其代谢产物间的转化。方法用固相萃取法处理样品,以泼尼松为内标物,C18硅胶键合相为固定相,甲醇-四氢呋喃-水(60∶2∶50)作流动相,在波长254 nm处紫外定量检测。结果MPA浓度在0.2~40 μg·mL-1范围内与色谱峰高呈良好线性关系,血浆MPA回收率为92.3%~103.1%,绝对回收率为50.2%~53.7%。最低检测极限为0.2μg·mL-1,批内与日间(n=5)RSD为3.34%和4.70%。结论本法用于MPA测定具有准确、灵敏、简便等特点,能满足临床常规血药浓度监测。
Abstract
OBJECTIVE To determine the concentration of mycophenolic acid (MPA) in plasma using a solidphase extraction and reversed phase high performance liquid chromatography.METHODS A solution of prednisone as the internal standard was added to a 0.2 mL plasma aliquot.The resulting sample was treated with water and dilute HCl and applied to a C18solid phase extraction column,a C18column (7μmparticle size,250mm×4.6mmID) was used with the temperature at 40℃.The mobile phase was consisted of methanol tetrahydrofuran water (60∶2∶50).The UV detection was at 254 nm. RESULTS The quantification limit was 0.2μg·mL-1and the linear range was over 0.2~40μg·mL-1.The coefficients of variation of within day and between day at 0.2μg·mL-1level were 3.34% and 4.70%,respectively.The recoveries of MPA were 92.3%~103.1%. CONCLUSION The method is reproducible,accurate and specific for MPA and can be used in routine determination.
关键词
麦考酚酸 /
肾移植 /
固相萃取 /
高效液相色谱
{{custom_keyword}} /
Key words
mycophenolic acid /
renal transplantation /
solid phase extraction /
HPLC
{{custom_keyword}} /
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1]The tricontinental mycophenolate mofetil transplantation study group.A blinded,randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation[J]. Transplantation, 1996,61:1029~1037.
[2]Schütz E,Shipkova M,Armstrong VW, et al. Therapecutic drug monitoring of mycophenolic acid:Comparison of HPLC and immunoassay reveals new MPA metabolites[J]. Transplant Proc, 1998,30:1185~1187.
[3]Langman LJ,LeGatt DF,Yatscoff RW.Blood distribution of mycophenolic acid[J]. Ther Drug Monit, 1994,16:602~607.
[4]Pirsch JD,Sollinger HW.Mycophenolate mofetil-clinical and experimental experience[J]. Ther Drug Monit, 1996,18:357~361.
[5]Nowak I,Shaw LM.Effect of mycophenolic acid glucuronide on inosine monophosphate dehydrogenase activity[J]. Ther Drug Monit, 1997,19:358~360.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}